Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No additions or deletions are listed. The supplied change data contains no textual changes for this page.
    Difference
    0.0%
    Check dated 2026-05-08T00:23:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a revision tag for v3.5.3, updating the page's revision history. The previous revision v3.5.2 is no longer the current tag, signaling a minor update to the page metadata.
    Difference
    0.0%
    Check dated 2026-04-30T17:42:16.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added revision label v3.5.2. Removed revision label v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:42:36.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:00:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:58:42.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added site revision label v3.4.2 and removed the lapse-in-government-funding notice (and the previous v3.4.1 revision).
    Difference
    0.4%
    Check dated 2026-02-11T05:49:46.000Z thumbnail image

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.